A point-prevalence survey that was conducted in the United States in 2011 showed that 4% of hospitalized patients had a health care-associated infection. We repeated the survey in 2015 to assess changes in the prevalence of health care-associated infections during a period of national attention to the prevention of such infections.
Health Care-Associated Infections in U.S. Hospitals H ealth care-associated infections are major threats to the safety of patients in the United States. Rates of selected health care-associated infections have become state and national metrics by which government agencies and consumers evaluate health care quality in hospitals. The National Healthcare Safety Network of the Centers for Disease Control and Prevention (CDC) tracks state and national progress regarding the prevention of health care-associated infections in thousands of U.S. health care facilities, 1 including approximately 3800 general, women's, and children's hospitals. When reporting data regarding health care-associated infections to the National Healthcare Safety Network, hospitals prioritize selected inpatient locations or infections that are included in federal, state, or local reporting mandates or qualityimprovement programs.
Point-prevalence surveys of health care-associated infections in health care settings complement location-or infection-specific National Healthcare Safety Network data, allowing public health officials and health care leaders to conduct periodic assessments of these infections to be considered for tracking and prevention. In 2011, the CDC conducted a hospital prevalence survey of health care-associated infections and the use of antimicrobial agents with the Emerging Infections Program, a network of 10 state health departments and academic collaborators. 2 A total of 4% of patients had a health care-associated infection. We used these data to generate national estimates of 648,000 patients with 721,800 health care-associated infections in U.S. hospitals in 2011. 3 Since 2011, efforts aimed at preventing health care-associated infections have continued to grow nationally, with a focus on antimicrobialresistant pathogens. [4] [5] [6] [7] [8] Although data that have been reported by hospitals to the National Healthcare Safety Network indicate national progress in reducing the incidence of specific health careassociated infections that have been targeted by prevention initiatives or reporting requirements, 9 it is not clear whether reductions in the risk of health care-associated infection have occurred across hospital locations. We repeated the survey in 2015 to assess changes in the prevalence of health care-associated infections.
Me thods

Hospitals and Patients
At 10 sites in the Emerging Infections Program (in California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee), we recruited general, women's, and children's hospitals in their survey catchment areas (Tables S1 and S2 in the Supplementary Appendix, available with the full text of this article at NEJM.org). Sites preferentially recruited hospitals that had participated in the 2011 survey. Sites engaged additional hospitals, up to 25 per site, by recruiting from randomly sorted hospital lists stratified according to hospital size (small, <150 beds; medium, 150 to 399 beds; or large, ≥400 beds) (see the Supplementary Appendix).
Each hospital selected a survey date from May 1 through September 30, 2015 . Random samples of patients in acute care locations were selected from hospitals' morning censuses on the survey date with the use of the method that had been used in the 2011 survey (see the Supplementary Appendix).
The CDC determined the survey to be a nonresearch activity. The Emerging Infections Program site and hospital review boards either considered the survey to be a nonresearch activity or approved the survey with a waiver of informed consent.
Data Collection and Management
Staff at the hospitals or the Emerging Infections Program sites reviewed medical records on the survey date or retrospectively (see the Supplementary Appendix) to collect basic demographic and clinical data, including information on whether devices were present on the survey date, and to identify patients who received or were scheduled to receive antimicrobial agents on the survey date or the day before the survey. Trained staff of the Emerging Infections Program retrospectively reviewed records of patients who were receiving or were scheduled to receive antimicrobial agents, in order to collect data regarding the use of antimicrobial agents on the survey date and the day before the survey.
Program staff also reviewed medical records for health care-associated infections if patients T h e ne w e ngl a nd jou r na l o f m e dicine were receiving antimicrobial agents for the treatment of an infection or for no documented rationale on the survey date or day before the survey. They identified and reported health care-associated infections for which signs and symptoms were present or for which antimicrobial treatment was given on the survey date. Two different National Healthcare Safety Network sets of definitions of health care-associated infections were used: the definitions used in the 2011 survey 10 and the definitions in place in 2015
11 (see the Supplementary Appendix). For comparisons of the prevalence of health care-associated infections in the two surveys, we included only the infections that were detected according to the 2011 definitions.
Program staff entered data into a Web-based data system developed at the CDC. Staff at the CDC reviewed the data from each site for errors and inconsistencies, and staff from the Emerging Infections Program re-reviewed medical records when necessary to verify data or make corrections.
Statistical Analysis
Extracts of patient data that were generated on November 16, 2017, were analyzed with the use of SAS software, versions 9.3 and 9.4 (SAS Institute), and OpenEpi software, version 3.01. 12 We compared the characteristics of the patients using chi-square or mid-P exact tests for categorical variables and median tests for continuous variables. We compared the percentages of patients who had health care-associated infections using mid-P exact tests. To account for characteristics of the patients and hospitals that might explain differences in the prevalence of health care-associated infections, we performed multivariable logbinomial regression modeling with survey year included as a covariate (see the Supplementary Appendix). A two-sided P value of 0.05 or less was considered to indicate statistical significance. National burden estimates for 2015 were developed with the use of a process that was similar to the method used in 2011, 3 with the 2014 National Inpatient Sample data (Healthcare Cost and Utilization Project, Agency for Healthcare Research and Quality) 13 In the 2015 survey, 4614 patients (37.5%) met the criterion for review of health care-associated infection by receiving antimicrobial agents for the treatment of an infection or receiving antimicrobial agents for which the rationale was not documented. This percentage was lower than that of patients who met the same review criterion in the 2011 survey (39.9%, P<0.001).
Prevalence of Health Care-Associated Infections
Applying the same definitions of health careassociated infections that had been used in 2011, we found that 394 of 12,299 patients in the 2015 survey had one or more health care-associated infections ( † The chi-square test was used for calculating the P value, unless otherwise indicated. The comparison excluded patients with missing data, unless otherwise indicated. ‡ Hospital size was determined according to the number of beds: fewer than 150 beds indicated small size, 150 to 399 beds indicated medium size, and 400 beds or more indicated large size. § By definition, all patients with a health care-associated infection were receiving antimicrobial agents at the time of the survey. ¶ The P value was calculated by a median two-sample test. The number of days from admission to survey was calculated by subtracting the admission date from the survey date; the length of stay in the hospital was calculated by subtracting the admission date from the discharge date. ‖ The analysis excluded seven patients who were still in the hospital 6 months after the survey date and one patient for whom the hospital discharge date was unknown. ** The analysis excluded one patient who was still in the hospital 6 months after the survey date. Solid-organ transplantation and dialysis units were classified as specialty care areas, and bone marrow transplantation and hematology-oncology units were classified as non-nursery ward locations. § The analysis excluded 11 patients in the 2011 survey who were screen-positive based on a special criterion for dialysis patients. This criterion was not implemented in the 2015 survey. ¶ The analysis included 7 patients who underwent medical record review for health care-associated infection because they met the antimicrobial use screening criterion for patients undergoing dialysis. This criterion was not implemented in the 2015 survey. ‖ The P value was calculated by a median two-sample test. The number of days from admission to survey was calculated by subtracting the admission date from the survey date. ** The comparison included only patients for whom the outcome was known (died vs. survived). Because the percentage of patients who met the criterion for review of health care-associated infection was lower in 2015 than in 2011, we also determined the prevalence of these infections in the subgroup of patients for whom review occurred. A total of 394 of 4614 patients (8.5%) who met the review criterion in 2015 had a health care-associated infection, as compared with 452 of 4504 patients (10.0%) in 2011 (P = 0.01).
After adjustment for age, time from admission to survey, presence of devices, and status of being in a large hospital, patients in the 2015 survey were 16% less likely to have a health care-associated infection than patients in the 2011 survey (risk ratio, 0.84; 95% CI, 0.74 to 0.95; P = 0.005) ( Table 3) . We repeated the analysis in the subgroup of patients who met the review criterion. After adjustment for similar factors, patients in the 2015 survey remained less * The total number of patients who were included in either survey was 23,581. One patient from the 2011 survey for whom age was unknown was excluded from the model. Other variables that were tested but found not to be significant predictors of the risk of health care-associated infection were survey month (May or June vs. July through September) and location of the patient in a critical care unit (yes vs. no). † The comparator group for the risk ratio was the group of patients in the 2011 survey. ‡ The comparator group for the risk ratio was the group of patients without a ventilator or for whom the presence of a ventilator was unknown. The presence of a ventilator was unknown for 36 patients without a health care-associated infection and for 1 with a health care-associated infection. § The comparator group for the risk ratio was the group of patients without a central catheter or for whom the presence of a central catheter was unknown. The presence of a central catheter was unknown for 62 patients without a health care-associated infection and for 2 with a health care-associated infection. ¶ The comparator group for the risk ratio was the group of patients without a urinary catheter or for whom the presence of a urinary catheter was unknown. The presence of a urinary catheter was unknown for 65 patients without a health care-associated infection and for 5 with a health care-associated infection. ‖ The comparator group for the risk ratio was the group of patients in small or medium hospitals. ** The model excluded 1 patient without a health care-associated infection for whom age was unknown. Results were similar in an analysis that was restricted to 148 hospitals that participated in both surveys. In these hospitals, the percentage of patients with a health care-associated infection was 3.2% (95% CI, 2.9 to 3.6) in 2015 (297 of 9169 patients), as compared with 4.1% (95% CI, 3.7 to 4.6) in 2011 (383 of 9283 patients) (P = 0.001). After adjustment for age, presence of devices, time from admission to survey, and status of being in a large hospital, patients in the 2015 survey had a 22% lower risk of health care-associated infections than patients in the 2011 survey (risk ratio, 0.78; 95% CI, 0.68 to 0.90; P<0.001) (Table S7 in the Supplementary Appendix).
Because the inclusion of the presence of a ventilator, central catheter, or urinary catheter in the model neutralizes the effect of reducing device use as a strategy for preventing health care-associated infections, we also evaluated the association of survey year with health careassociated infections in a model that did not adjust for the presence of a device. In this model, patients in the 2015 survey had a 24% lower risk of health care-associated infection than patients in the 2011 survey (risk ratio, 0.76; 95% CI, 0.66 to 0.87; P<0.001) ( Table S8 in the Supplementary Appendix).
Types of Health Care-Associated Infection
There were 427 health care-associated infections in 394 patients in the 2015 survey. Pneumonia was the most common infection, followed by gastrointestinal infections (most of which were due to Clostridium difficile [now Clostridioides difficile]), and surgical-site infections (Table 4 ). Although the percentages of patients with pneumonia, gastrointestinal infection (including C. difficile infection), or bloodstream infection did not differ significantly between 2015 and 2011, the percentages of patients with a surgical-site infection or urinary tract infection were lower in 2015 than in 2011 ( Among the 358 health care-associated infections that were not surgical-site infections, the inpatient location to which the infection was attributed was reported for 346 infections. Of these, 126 infections (36.4%) were attributed to critical care locations, 199 (57.5%) to ward or nursery locations, and 21 (6.1%) to step-down or specialty care units or to units that house patients receiving different levels of acute care (known as mixed acuity locations in surveillance of the National Healthcare Safety Network).
Pathogens Causing Health Care-Associated Infection
At least 1 pathogen was reported for 300 of 427 health care-associated infections (70.3%). Of 392 total pathogens, C. difficile, Staphylococcus aureus, and Escherichia coli were the most common, with each being reported for 10% or more of all health care-associated infections (Table 5) . Among 47 S. aureus isolates with antimicrobial susceptibility results, 21 (45%) were methicillin resistant (MRSA). Among 66 E. coli, klebsiella, and enterobacter isolates with susceptibility results that were reported for at least one carbapenem, 3 (5%) were resistant.
National Estimates of Health Care-Associated Infections in Hospitals in 2015
The age of the patients, the presence of a ventilator or central catheter, the length of stay in the hospital, the number of beds for which the hospital was licensed, and hospital location (rural vs. urban) were independently associated with the prevalence of health care-associated infections in the final log-binomial regression model (Table S9 in the Supplementary Appendix). A reduced model included factors that were present in both the 2015 prevalence survey and the National Inpatient Sample data sets: the age of the patient, length of stay, and hospital location. Hospital location was removed because statistical significance was not sustained after bootstrap validation. The final model that was used to obtain parameter estimates for the estimation of burden included the age of the patient and length T h e ne w e ngl a nd jou r na l o f m e dicine (11) 13 (12) 2 (2) 12 (17) 12 (23) 0
(14)
Escherichia coli 44 (10) 2 (2) 1 (1) 13 (19) 4 (8) 18 (46) 6 (9) Candida species 26 (6) 7 (6) 3 (3) 1 (1) 7 (13) 3 (8) 5 (8) Enterococcus species
23 (5) 1 (1) 2 (2) 8 (12) 6 (12) 4 (10) 2 (3) Enterobacter species † † 22 (5) 3 (3) 1 (1) 10 (14) 0 3 (8)
(8)
Pseudomonas aeruginosa
22 (5) 8 (7) 2 (2) 3 (4) 0 5 (13)
(6)
Klebsiella pneumoniae or K. oxytoca
1 (1) 3 (4) 3 (6) 7 (18) 1 (2) Streptococcus species ‡ ‡ 21 (5) 4 (4) 1 (1) 9 (13) 6 (12) 0 1 (2) Coagulase-negative staphylococcus 16 (4) 1 (1) 2 (2) 6 (9) 6 ( (6) 1 (2) 1 (3) 3 (5)
Proteus mirabilis
1 (2) 3 (8) 1 ( 64 (58) 16 (18) 19 (28) 0 0 28 (42) of stay ( 
Discussion
In this point-prevalence survey conducted in multiple states, we found that health care-associated infections affected 3.2% of hospitalized patients -a significantly lower percentage than we observed in a survey that had been conducted in 2011. These results provide evidence of national success in preventing health care-associated infections, particularly surgical-site and urinary tract infections. In contrast, there was no significant reduction in the prevalence of pneumonia or C. difficile infection, nor in the percentage of patients with health care-associated infection who died during their hospitalization, which suggests that more work is needed to prevent these infection types and reduce mortality among patients with health care-associated infections. Although the prevalence of health care-associated infections was significantly lower in 2015 than in 2011, we did not directly compare the national burden estimates from the two surveys. Two barriers to such a comparison were present. First, there were differences in the variables that remained in the best-fitting multivariable regression models that were used in the 2011 and 2015 burden-estimation processes. For example, we lacked complete data regarding the length of stay in the hospital for patients in the 2011 survey and therefore used a proxy measure (the number of days from admission to the survey). In addition, the Nationwide Inpatient Sample underwent a redesign starting with 2012 data and was renamed the National Inpatient Sample. 15 Despite differences in the methods used in the prevalence survey and in National Healthcare Safety Network surveillance, similar signals have emerged from these complementary systems, providing evidence of improvements in the safety of patients in U.S. hospitals. Analyses of National Healthcare Safety Network data through 2014, before the implementation of major chang-es in the definitions of health care-associated infections, showed reductions in the standardized infection ratios for central catheter-associated bloodstream infections between 2008 and 2014, selected surgical-site infections between 2008 and 2014, and MRSA bacteremia between 2011 and 2014. 9 There was no reduction in the standardized infection ratio for catheterassociated urinary tract infections in hospitals nationally from 2009 to 2014, but a significant decrease in the standardized infection ratio was evident from 2013 to 2014. 9 We observed significant reductions in the prevalence of urinary tract infections and surgical-site infections. Experience has shown that health care-associated infections can be prevented by means of evidence-based interventions; for example, implementation of a Comprehensive Unit-based Safety Program that was focused on catheter-associated urinary tract infection in 603 U.S. hospitals between 2011 and 2013 led to a reduction in the rates of catheter-associated urinary tract infection and urinary-catheter use. 16 Reductions in urinary-catheter use, which we observed in the survey, may partially explain the lower prevalence of urinary tract infection. Although we did not collect data on urine-culturing practices, increased focus on improving the diagnosis and treatment of urinary tract infection in recent years may also have contributed. 17 The reduction in the prevalence of surgical-site infections may reflect the uptake of preoperative infection-prevention practices, such as the decolonization of patients with S. aureus colonization, [18] [19] [20] or the use of updated surgical prophylaxis guidelines. 21 A limitation of our survey is that we do not have data to evaluate practice changes, nor do we have information about changes in the volume or types of operative procedures that may have affected the overall prevalence of surgical-site infections.
Our survey showed that pneumonia was the most common health care-associated infection, with a stable prevalence between 2011 and 2015. Similarly, an analysis of Medicare Patient Safety Monitoring System data showed that, between 2005 and 2013, the percentage of patients with ventilator-associated pneumonia among eligible Medicare patients with selected diagnoses who were undergoing mechanical ventilation remained the same, at approximately 10%. 22 Although the prevention of ventilator-associated pneumonia remains an important goal, the majority of pneumonia events in hospitals in our survey were not ventilator-associated. The published literature contains relatively little regarding the prevention of non-ventilator-associated pneumonia in hospitalized patients, despite the association of this infection with poor outcomes in some reports. 23, 24 Some investigators have called for increased attention and resources for this underappreciated health care-associated infection. [25] [26] [27] We also found that the prevalence of C. difficile infection was stable between 2011 and 2015. However, we did not collect data on changes in the use of nucleic acid amplification tests for the diagnosis of C. difficile infection in participating hospitals from 2011 to 2015. Others have suggested that increasing the use of such tests may result in an increased incidence of C. difficile infection owing to overdiagnosis. 28, 29 It is possible that an increased use of nucleic acid amplification tests in survey hospitals masked actual reductions in the prevalence of C. difficile infection. Analyses of National Healthcare Safety Network data have begun to show progress regarding the prevention of C. difficile infection with onset in the hospital. 9 Regardless of whether changes in testing have inflated our estimate of the burden of C. difficile infection in hospitals, there is room for improvement. Because the use of antibiotics is a major driver of C. difficile infections as well as antimicrobial resistance, continued focus on improving practices for the prescribing of antibiotics is critical, in addition to infection-control measures to prevent transmission in hospitals.
Our survey has other potential limitations. As in the 2011 survey, the 2015 survey included geographically diverse sites, but the results may not be generalizable to all U.S. hospitals. Owing to the types of data available in the National Inpatient Sample, we were unable to account for all the factors associated with the prevalence of health care-associated infections in the process of developing national burden estimates. In the 2015 survey, we used the same antimicrobial screening criterion that had been used in 2011 to identify patients for review of health care-associated infections. 3, 30 In 2015, the proportion of patients who met the screening criterion was significantly lower than in 2011. This resulted in a lower proportion of medical records being reviewed for health care-associated infections and potentially could have resulted in the detection of fewer health care-associated infections. However, analyses of the prevalence of health care-associated infections among just those patients for whom review was performed confirmed that a smaller percentage of patients had a health care-associated infection in 2015 than in 2011, even after adjustment for other factors. Additional limitations are discussed in the Supplementary Appendix.
Prevalence surveys capture the range and relative frequencies of all health care-associated infections among hospitalized patients and complement ongoing tracking of these infections. The health care-associated infections that we identified in this survey are only one portion of the overall burden of such infections, which includes infections that occur in other settings, such as nursing homes. The CDC and the Emerging Infections Program sites are collaborating on a large-scale nursing home prevalence survey to address this gap. 31 Collaborations among health care facilities, public health agencies, and other partners, bolstered by recent increases in support for programs regarding health care-associated infections, will be critical to the continued progress toward the goal of eliminating health care-associated infections.
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